Climb Bio Correlations
| CLYM Stock | 1.95 0.08 3.94% |
The current 90-days correlation between Climb Bio and Dogwood Therapeutics, is 0.04 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Climb Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Climb Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Climb Bio Correlation With Market
Significant diversification
The correlation between Climb Bio and DJI is 0.03 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Climb Bio and DJI in the same portfolio, assuming nothing else is changed.
Climb |
Moving together with Climb Stock
| 0.74 | DWTX | Dogwood Therapeutics, Symbol Change | PairCorr |
| 0.74 | EFTR | Effector Therapeutics | PairCorr |
| 0.73 | EMMA | Emmaus Life Sciences | PairCorr |
| 0.77 | FNCH | Finch Therapeutics | PairCorr |
| 0.71 | ENSCW | Ensysce Biosciences | PairCorr |
| 0.8 | IRD | Opus Genetics, Symbol Change | PairCorr |
| 0.84 | HRGN | Harvard Apparatus | PairCorr |
| 0.76 | ZIVO | Zivo Bioscience | PairCorr |
| 0.71 | KRBP | Kiromic Biopharma | PairCorr |
| 0.66 | LADX | LadRx | PairCorr |
| 0.82 | MTVA | MetaVia Symbol Change | PairCorr |
| 0.77 | NAVB | Navidea Biopharmaceutica | PairCorr |
| 0.73 | NEXI | Neximmune | PairCorr |
| 0.73 | NWBO | Northwest Biotherapeutics | PairCorr |
| 0.75 | ONCT | Oncternal Therapeutics | PairCorr |
| 0.66 | ORGS | Orgenesis | PairCorr |
Moving against Climb Stock
| 0.65 | GRCE | Grace Therapeutics, Symbol Change | PairCorr |
| 0.63 | EPRX | Eupraxia Pharmaceuticals | PairCorr |
| 0.57 | FRTX | Fresh Tracks Therapeutics | PairCorr |
| 0.56 | VAXX | Vaxxinity | PairCorr |
| 0.48 | FBIOP | Fortress Biotech Pref | PairCorr |
| 0.41 | CEROW | CERo Therapeutics Symbol Change | PairCorr |
| 0.38 | EVLO | Evelo Biosciences | PairCorr |
| 0.79 | LBPH | Longboard Pharmaceuticals | PairCorr |
| 0.55 | XOMAO | XOMA | PairCorr |
Related Correlations Analysis
| -0.61 | -0.64 | 0.68 | 0.09 | DWTX | ||
| -0.61 | 0.7 | -0.68 | -0.01 | EPRX | ||
| -0.64 | 0.7 | -0.58 | -0.16 | CEROW | ||
| 0.68 | -0.68 | -0.58 | 0.09 | IRD | ||
| 0.09 | -0.01 | -0.16 | 0.09 | TLX | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Climb Stock performing well and Climb Bio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Climb Bio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| DWTX | 7.67 | (0.52) | 0.00 | (0.70) | 0.00 | 15.01 | 69.76 | |||
| EPRX | 3.66 | 0.23 | 0.05 | (0.49) | 3.86 | 10.43 | 34.56 | |||
| CEROW | 26.34 | 5.11 | 0.20 | (1.73) | 22.06 | 66.67 | 191.74 | |||
| IRD | 4.01 | (0.33) | 0.00 | (0.22) | 0.00 | 9.77 | 29.54 | |||
| TLX | 1.67 | 0.18 | 0.07 | (0.94) | 1.72 | 4.38 | 10.19 |
Climb Bio Corporate Executives
Elected by the shareholders, the Climb Bio's board of directors comprises two types of representatives: Climb Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Climb. The board's role is to monitor Climb Bio's management team and ensure that shareholders' interests are well served. Climb Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Climb Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.